- Activity pressure is positive on the latest completed week.
P1RG34
SAO
Week ended 07 Aug 2026
Weekly Investor Report
Perrigo Company plc · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
51.75 BRL
0.4%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -10.9% below the Trend Line and sits at 4.1% of its 52-week range. The latest completed week returned 0.4%, after a 0.0% four-week move. The latest news-sentiment score is 50/100.
Setup score
21
out of 100
Latest Close
51.75 BRL
7 Aug 2026
1W Return
0.4%
latest completed week
4W Return
0.0%
short-term follow-through
12W Return
-1.1%
quarterly tape
Trend Breadth
0.0%
0 of 52 weeks active
Volume Ratio
-
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 20.69% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
Price follow-through
0.4%
Latest completed week; four-week move 0.0%.
Indicator stack
0/59
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 20.69%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
6 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -10.9% below the Trend Line and sits at 4.1% of its 52-week range. The latest completed week returned 0.4%, after a 0.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is - the 13-week average. Participation data is incomplete.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1412-week average 0.08
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.14Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 0.0% over four weeks, -1.1% over 12 weeks, and -54.8% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.57Latest activity-pressure read.
Pressure change-12.9%Four-week change in activity pressure.
Leadership-35.64Latest relative-leadership reading.
RS change19.0%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 6 relevant articles.
0 positive · 6 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-59.3%Distance below the 52-week high.
13-week volatility5.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2610 weeks finished lower.
Best week+13.9%Week of 3 Apr.
Worst week-24.1%Week of 6 Mar.
Latest week+0.4%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains8
Flat weeks4
Modest losses5
Sharp losses5
Recent vol5.1%13-week weekly-return volatility.
Base vol7.7%52-week weekly-return volatility.
Up/down split19/19Count of positive and negative weeks in the 52-week window.
Average skew4.5% / -7.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorBR Healthcare
4-week rank39 / 82
Group average-0.7%
Trend breadth35.4%
Trend35.4%active weekly trend signals
MD65.9%positive activity pressure
RS46.3%positive relative leadership
Four-week leaders
IndustryBR Drug Manufacturers - Specialty & Generic
4-week rank3 / 9
Group average-2.9%
Trend breadth22.2%
Trend22.2%active weekly trend signals
MD33.3%positive activity pressure
RS44.4%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape18/100
Trend, activity pressure, participation, and risk combine to a 18/100 tape read.
Indicator analysis32/100Latest 12-week confirmation: trend 0/12, activity pressure 12/12, relative leadership 0/12.
Activity pressure 0.14; No reversal markers Next-Week ExpectancyNegative 20.69%Next-week expectancy is negative with a 20.69% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 6 relevant articles.
Perrigo Company PLC Shs Unsponsored Brazilian Depositary Receipt Repr 1 Sh Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 51.75 BRL | 0.4% | 58.11 BRL | 115.9 BRL | 0.57 | -35.64 | 0 | Off |
| 31 Jul 2026 | 51.53 BRL | 0.0% | 58.89 BRL | 116.5 BRL | 0.54 | -39.25 | 0 | Off |
| 24 Jul 2026 | 51.53 BRL | 1.6% | 59.65 BRL | 117.2 BRL | 0.55 | -39.70 | 600 | Off |
| 17 Jul 2026 | 50.70 BRL | -2.0% | 60.41 BRL | 117.8 BRL | 0.57 | -42.23 | 1 | Off |
| 10 Jul 2026 | 51.74 BRL | 0.0% | 61.02 BRL | 118.4 BRL | 0.66 | -44.00 | 0 | Off |
| 3 Jul 2026 | 51.74 BRL | 0.0% | 61.63 BRL | 119.0 BRL | 0.79 | -44.33 | 0 | Off |
| 26 Jun 2026 | 51.74 BRL | -1.0% | 62.23 BRL | 119.7 BRL | 0.73 | -45.36 | 81 | Off |
| 19 Jun 2026 | 52.25 BRL | -8.2% | 62.93 BRL | 120.3 BRL | 0.67 | -44.65 | 0 | Off |
| 12 Jun 2026 | 56.94 BRL | 8.6% | 63.29 BRL | 120.9 BRL | 0.55 | -41.97 | 0 | Off |
| 5 Jun 2026 | 52.45 BRL | -5.9% | 63.70 BRL | 121.5 BRL | 0.28 | -47.08 | 0 | Off |
| 29 May 2026 | 55.72 BRL | 0.5% | 64.36 BRL | 122.3 BRL | 0.26 | -46.55 | 16 | Off |
| 22 May 2026 | 55.44 BRL | 5.9% | 66.04 BRL | 123.1 BRL | 0.15 | -48.68 | 14 | Off |
| 15 May 2026 | 52.34 BRL | -11.1% | 68.01 BRL | 123.9 BRL | 0.04 | -52.85 | 49 | Off |
| 8 May 2026 | 58.87 BRL | 1.9% | 70.08 BRL | 124.7 BRL | -0.02 | -49.99 | 1 | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.